The overall objective of the present proposal is to define further the cellular and molecular mechanisms underlying the ontogenic expression of hepatic bile acid transport. It is our hypothesis that the developmental regulation of these proteins which mediate uptake and secretion of bile acids occurs predominantly at the level of transcription in response to ontogenic programming, the hormonal milieu, and an increasing substrate [ bile acid ] pool. The following specific aims are designed to test this hypothesis as well as to determine if alternative or complementary mechanisms (translational and post-translational) are involved in the process.
The specific aims are to determine: (1) the factors involved in the developmental expression of the basolateral Na+-dependent and the canalicular potential-driven bile acid transporters; (2) the number of canalicular bile acid transporters, their driving forces [potential vs. ATP dependent] and their expression during perinatal development; and (3) the molecular mechanisms underlying the ontogenic and tissue-specific expression of the basolateral and canalicular bile acid transporters. An integrated experimental approach will employ membrane vesicle transport assays, immunochemical quantitation and immunocytochemical localization of the transport proteins, and Northern blot analysis of transporter mRNA levels. These studies will determine whether the canalicular ATP-dependent bile acid transporter is functional in neonatal liver and whether its activity can be distinguished from the potential- driven system through its pattern of expression and through selective reconstitution of transport activity into synthetic proteoliposomes. The cloning of the basolateral Na+-dependent and the canalicular potential- driven bile acid transporter genes including their promoters will allow the identification of regulatory elements involved in the ontogenesis of transport activity and mediating the effects of hormones and bile acids on gene transcription. The cis-acting elements and trans-acting factors that direct the liver-specific and ontogenic expression of these transporters will be defined through an analysis of DNA and nuclear protein interactions. The cis-regulatory regions of these genes will be characterized further by linking various portions of the promoter regions to a firefly luciferase reporter for transfection assays in cultured primary rat hepatocytes. The ability of bile acids to regulate the promoter activities of the transporters will be investigated in experiments utilizing in vitro transfection assays. Transgenic mice will be used to assess DNA regulatory regions required to direct the correct acinar, developmental, and tissue-specific pattern for expression of the Na+-dependent bile acid transporter. These studies will provide further insights into the factors contributing to the physiologic immaturity of hepatic excretory function and susceptibility to cholestatic liver disease in the newborn.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD020632-10
Application #
2198058
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1985-09-01
Project End
1998-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Yale University
Department
Pediatrics
Type
Schools of Medicine
DUNS #
082359691
City
New Haven
State
CT
Country
United States
Zip Code
06520
Geier, Andreas; Martin, Ina V; Dietrich, Christoph G et al. (2008) Hepatocyte nuclear factor-4alpha is a central transactivator of the mouse Ntcp gene. Am J Physiol Gastrointest Liver Physiol 295:G226-33
Frankenberg, Tamara; Miloh, Tamir; Chen, Frank Y et al. (2008) The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor. Hepatology 48:1896-905
Molina, Hector; Azocar, Lorena; Ananthanarayanan, Meenakshisundaram et al. (2008) Localization of the Sodium-Taurocholate cotransporting polypeptide in membrane rafts and modulation of its activity by cholesterol in vitro. Biochim Biophys Acta 1778:1283-91
Li, Hai; Chen, Frank; Shang, Quan et al. (2005) FXR-activating ligands inhibit rabbit ASBT expression via FXR-SHP-FTF cascade. Am J Physiol Gastrointest Liver Physiol 288:G60-6
Anwer, M Sawkat; Gillin, Henry; Mukhopadhyay, Sunil et al. (2005) Dephosphorylation of Ser-226 facilitates plasma membrane retention of Ntcp. J Biol Chem 280:33687-92
Geier, Andreas; Dietrich, Christoph G; Voigt, Sebastian et al. (2005) Cytokine-dependent regulation of hepatic organic anion transporter gene transactivators in mouse liver. Am J Physiol Gastrointest Liver Physiol 289:G831-41
Balasubramaniyan, N; Shahid, Mohammad; Suchy, Frederick J et al. (2005) Multiple mechanisms of ontogenic regulation of nuclear receptors during rat liver development. Am J Physiol Gastrointest Liver Physiol 288:G251-60
Dubrac, Sandrine; Lear, Steven R; Ananthanarayanan, Meena et al. (2005) Role of CYP27A in cholesterol and bile acid metabolism. J Lipid Res 46:76-85
Wood, M; Ananthanarayanan, M; Jones, B et al. (2005) Hormonal regulation of hepatic organic anion transporting polypeptides. Mol Pharmacol 68:218-25
Chen, Frank; Ananthanarayanan, M; Emre, Sukru et al. (2004) Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity. Gastroenterology 126:756-64

Showing the most recent 10 out of 54 publications